The ‘aggressive and tactical litigation team’ at Kasowitz Benson Torres LLP in New York acts for both plaintiffs and defendants in securities litigation. Its defense work is frequently for large and public national and international companies. The firm recently negotiated a $430m cash settlement for Teva Pharmaceuticals in one of the largest securities class actions in recent years. Sheron Korpus, Michael Hanin and Stephen Tountas lead the ‘incredibly responsive and technical’ practice, in which emerging partner talent Andrew Schwartz plays an increasingly prominent role.
Testimonials
Collated independently by Legal 500 research team.
‘Aggressive and tactical litigation team.’
‘Pragmatic and able to see through the fog in order to get to a resolution.’
‘Incredibly responsive and technical but never losing sight of the commerciality needed in securities litigation.’
Key clients
- Teva Pharmaceuticals
- Howard Meyers, chairman of Eco-Bat Technologies
- Prem Parameswaran, the former CFO of Eros Int’l
- Pilgrim’s Pride
Work highlights
- Represented Teva Pharmaceuticals and its individual directors and officers in defense of one of the largest securities class actions currently pending as well as the more than 20 related direct actions, filed on behalf of more than 75 opt-out plaintiffs.
- Representing Prem Parameswaran, the former CFO of Eros Int’l, in connection with a putative securities class action arising from a series of alleged misrepresentations.
Practice head
The lawyer(s) leading their teams.
Sheron Korpus, Michael Hanin, Stephen Tountas